The future of cancer data analysis lies in the continued advancement of technologies and methodologies. Artificial intelligence (AI) and machine learning are expected to play increasingly significant roles in predicting cancer outcomes, identifying new drug targets, and personalizing treatment plans. Collaborative efforts and data sharing among researchers, clinicians, and institutions will also be essential in overcoming the challenges posed by cancer data complexity.
